First Pediatric Case of Coronavirus Disease 2019 in Korea

Ji Young Park1, Mi Seon Han2, Kyoung Un Park3

  • 1Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.

Insights

The first pediatric case of coronavirus disease 2019 (COVID-19) in Korea involved a 10-year-old girl with mild pneumonia. This case highlights the need for specific pediatric infection control strategies and quarantine guidelines.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Pediatrics

Background:

  • The global outbreak of coronavirus disease 2019 (COVID-19) has raised concerns about its impact on all age groups.
  • Limited data exists on pediatric COVID-19 cases, hindering understanding of disease transmission and management in children.
  • Children may play a role in community viral spread, necessitating specific infection control measures.

Observation:

  • This report details the first confirmed pediatric case of COVID-19 in Korea.
  • The patient was a 10-year-old girl with a history of close contact with confirmed adult cases (mother and uncle).

Findings:

  • The child presented with mild pneumonia, not requiring antiviral therapy.
  • Serial viral testing from multiple specimens was conducted, providing valuable data on viral shedding.
  • The clinical course was characterized by mild symptoms and recovery.

Implications:

  • This case underscores the importance of considering pediatric involvement in COVID-19 outbreaks.
  • Optimal strategies for self-quarantine and patient care in negative isolation rooms for children require further investigation.
  • Understanding pediatric COVID-19 is crucial for comprehensive public health strategies and infection control measures.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
923
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
715
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
180
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
374